Related references
Note: Only part of the references are listed.Dietary Cholesterol Exacerbates Statin-Induced Hepatic Toxicity in Syrian Golden Hamsters and in Patients in an Observational Cohort Study
Qiongyang Yu et al.
CARDIOVASCULAR DRUGS AND THERAPY (2021)
Safety and Effectiveness of Aflibercept plus Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study
Ian Chau et al.
CANCERS (2020)
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
Karla B. Neves et al.
CARDIOVASCULAR RESEARCH (2019)
Profound Decrease in Glomerular Arginine Transport by CAT (Cationic Amino Acid Transporter)-1 Contributes to the FLT-1 (FMS-Like Tyrosine Kinase 1) Induced Preeclampsia in the Pregnant Mice
Moshe Shashar et al.
HYPERTENSION (2019)
L-Arginine Inhibited Inflammatory Response and Oxidative Stress Induced by Lipopolysaccharide via Arginase-1 Signaling in IPEC-J2 Cells
Yueqin Qiu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Strong and Sustained Antihypertensive Effect of Small Interfering RNA Targeting Liver Angiotensinogen
Estrellita Uijl et al.
HYPERTENSION (2019)
Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma The GEMCAD 1402 Randomized Clinical Trial
Carlos Fernandez-Martos et al.
JAMA ONCOLOGY (2019)
Quantifying the relationship between inhibition of VEGF receptor 2, drug-induced blood pressure elevation and hypertension
Teresa Collins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
L-Arginine induces antioxidant response to prevent oxidative stress via stimulation of glutathione synthesis and activation of Nrf2 pathway
Mingcai Liang et al.
FOOD AND CHEMICAL TOXICOLOGY (2018)
Oxidized low-density lipoprotein stimulates epithelial sodium channels in endothelial cells of mouse thoracic aorta
Chen Liang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition
Rhian M. Touyz et al.
HYPERTENSION (2017)
Vascular Endothelial Growth Factor Augments Arginine Transport and Nitric Oxide Generation via a KDR Receptor Signaling Pathway
Moshe Shashar et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
Sex differences in vascular physiology and pathophysiology: estrogen and androgen signaling in health and disease
Austin C. Boese et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Genetic and Pharmacologic Inhibition of the Chemokine Receptor CXCR2 Prevents Experimental Hypertension and Vascular Dysfunction
Lei Wang et al.
CIRCULATION (2016)
Molecular mechanisms for vascular complications of targeted cancer therapies
Srila Gopal et al.
CLINICAL SCIENCE (2016)
Ten years of anti-vascular endothelial growth factor therapy
Napoleone Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Javid J. Moslehi
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and-2, in a Mouse Model of Hepatocellular Carcinoma
Takuji Torimura et al.
NEOPLASIA (2016)
Mechanisms and consequences of endothelial nitric oxide synthase dysfunction in hypertension
Qiang Li et al.
JOURNAL OF HYPERTENSION (2015)
Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP
Nan Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Vascular and Metabolic Implications of Novel Targeted Cancer Therapies Focus on Kinase Inhibitors
Weijuan Li et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Clinical Risk Factors for the Development of Hypertension in Patients Treated With Inhibitors of the VEGF Signaling Pathway
Ole-Petter R. Hamnvik et al.
CANCER (2015)
Ginsenoside Rb3 attenuates oxidative stress and preserves endothelial function in renal arteries from hypertensive rats
Youhua Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Inhibition of Toll-like receptor 2 reduces cardiac fibrosis by attenuating macrophage-mediated inflammation
Lei Wang et al.
CARDIOVASCULAR RESEARCH (2014)
Risk of Hypertension in Cancer Patients Treated with Aflibercept: A Systematic Review and Meta-Analysis
Wei-Xiang Qi et al.
CLINICAL DRUG INVESTIGATION (2014)
Capacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cells
Heidrun L. Deissler et al.
EXPERIMENTAL EYE RESEARCH (2014)
Nitric oxide inhibits the production of soluble endothelin converting enzyme-1
Sanjaya Kuruppu et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Oxidative stress and endothelial dysfunction: Clinical evidence and therapeutic implications
Yukihito Higashi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2014)
Hyperglycemia induces differential change in oxidative stress at gene expression and functional levels in HUVEC and HMVEC
Hemang Patel et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
Cardiovascular and Systemic Microvascular Effects of Anti-Vascular Endothelial Growth Factor Therapy for Cancer
J. Todd Belcik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Improvement of endothelial nitric oxide synthase activity retards the progression of diabetic nephropathy in db/db mice
Huifang Cheng et al.
KIDNEY INTERNATIONAL (2012)
Anti-vascular endothelial growth factor treatment for eye diseases
Ning Cheung et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
The interaction between endothelin-1 and nitric oxide in the vasculature: new perspectives
Stephane L. Bourque et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2011)
Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR
Ana M. Briones et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2011)
Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels
Mariette H. W. Kappers et al.
HYPERTENSION (2010)
Effects of Exercise and L-Arginine on Ventricular Remodeling and Oxidative Stress
Xiaohua Xu et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2010)
Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
Michael L. Maitland et al.
CLINICAL CANCER RESEARCH (2009)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Lee M. Ellis et al.
NATURE REVIEWS CANCER (2008)
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
John S. Rudge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Low-dose L-arginine administration increases microperfusion of hindlimb muscle without affecting blood pressure in rats
Fumio Ohta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury - Comparative effects of rapamycin and cyclosporine
Danny Ramzy et al.
CIRCULATION (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Reciprocal relationships between insulin resistance and endothelial dysfunction - Molecular and pathophysiological mechanisms
JA Kim et al.
CIRCULATION (2006)
Chronic estrogen treatment modifies insulin-induced insulin resistance and hypertension in ovariectomized rats
DZ Song et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Inhibition of endothelial nitric oxide generation by low-density lipoprotein is partially prevented by L-arginine and L-ascorbate
Y Ji et al.
ATHEROSCLEROSIS (2004)
Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
U Landmesser et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Abnormal vascular function and hypertension in mice deficient in estrogen receptor β
Y Zhu et al.
SCIENCE (2002)
Share Paper
